^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

Serotonin 1A-2A-2B-2C receptor antagonist

6d
Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole (clinicaltrials.gov)
P4, N=350, Recruiting, Vanderbilt University Medical Center | Trial primary completion date: Jul 2024 --> Jul 2025
Trial primary completion date
18d
CHILL-1: Study on Hibernation-like Therapy Based on Mechanical Thrombectomy (clinicaltrials.gov)
P1, N=32, Recruiting, Capital Medical University | Not yet recruiting --> Recruiting
Enrollment open
|
chlorpromazine
19d
Structural basis for the transmembrane signaling and antidepressant-induced activation of the receptor tyrosine kinase TrkB. (PubMed, Nat Commun)
We verify the structure using mutagenesis and confirm that the conformation corresponds to the active state of the receptor. Subsequent study of TrkB interaction with the antidepressant drug fluoxetine, and the antipsychotic drug chlorpromazine, provides a clear self-consistent model, describing the mechanism by which fluoxetine activates the receptor by binding to its transmembrane domain.
Journal
|
NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2)
|
chlorpromazine • fluoxetine
21d
New P1 trial
|
chlorpromazine
1m
FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in nasopharyngeal carcinoma. (PubMed, Oral Oncol)
Previous studies have shown that chlorpromazine (CPZ) can inhibit YAP1 expression...Collectively, our findings indicate that FOXP3 competitively binds TEAD4 to regulate YAP1 localization in the nucleus and cytoplasm to suppress NPC progression. Consequently, FOXP3 may be a prognostic indicator for HNSCC.
Journal
|
YAP1 (Yes associated protein 1) • FOXP3 (Forkhead Box P3) • TEAD4 (TEA Domain Transcription Factor 4)
|
FOXP3 expression
|
chlorpromazine
2ms
Efficacy of chlorpromazine as a adjunctive therapy for esketamine on major depression: a randomized controlled trial (ChiCTR2400084824)
P=N/A, N=338, Suspended, The Affiliated Hospital of Shandong Second Medical University; The Affiliated Hospital of Shandong Second Medical University | Not yet recruiting --> Suspended
Trial suspension
|
chlorpromazine
2ms
OCD-RT: Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD) (clinicaltrials.gov)
P2, N=0, Withdrawn, Clinical Academic Center (2CA-Braga) | N=52 --> 0 | Not yet recruiting --> Withdrawn
Enrollment change • Trial withdrawal
3ms
Trial completion
|
chlorpromazine
4ms
Chlorpromazine overcomes temozolomide resistance in glioblastoma by inhibiting Cx43 and essential DNA repair pathways. (PubMed, J Transl Med)
Chlorpromazine potentiates the cytotoxic effects of the alkylating agent temozolomide through a mechanism involving downregulation of Cx43 expression and disruption of the cell cycle arrest essential for DNA repair processes. This finding suggests that chlorpromazine may be a potential therapeutic strategy to overcome TMZ resistance in GBM cells by inhibiting their DNA repair mechanisms.
Journal
|
MGMT (6-O-methylguanine-DNA methyltransferase) • GJA1 (Gap Junction Protein Alpha 1)
|
temozolomide • chlorpromazine
4ms
reCoVery: Repurposing of Chlorpromazine in Covid-19 Treatment (clinicaltrials.gov)
P3, N=0, Withdrawn, Centre Hospitalier St Anne | N=40 --> 0 | Unknown status --> Withdrawn
Enrollment change • Trial withdrawal
|
CD8 (cluster of differentiation 8) • IL6 (Interleukin 6) • CD4 (CD4 Molecule) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
|
chlorpromazine
5ms
Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy (clinicaltrials.gov)
P2/3, N=11, Active, not recruiting, M.D. Anderson Cancer Center | Enrolling by invitation --> Active, not recruiting | N=150 --> 11
Enrollment closed • Enrollment change
|
chlorpromazine
5ms
Persistent hiccups after acute COVID-19 successfully treated with chlorpromazine: a case report. (PubMed, J Med Case Rep)
This is one of the few published cases of COVID-19 associated persistent hiccups, occurring more than a month after the initial presentation. Most of the published cases report hiccups occurring in the acute COVID-19 period. Consequently, hiccups occurring in the post-acute COVID-19 period may not be attributable to COVID-19. This case has highlighted the need to consider post-acute COVID-19 in the differential diagnosis of persistent hiccup.
Journal
|
CRP (C-reactive protein)
6ms
Phase classification
6ms
The anti-inflammatory effects of antidepressants on colitis. (PubMed, Gastroenterol Hepatol Bed Bench)
Clomipramine showed the best anti-inflammatory effect compared to Escitalopram and Risperidone. Therefore, clomipramine showed the best relieving effect on inflammation of ulcerative colitis in rats.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • MPO (Myeloperoxidase)
7ms
VCFS: The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (clinicaltrials.gov)
P4, N=400, Recruiting, The Chaim Sheba Medical Center | Trial completion date: Dec 2022 --> Aug 2024 | Trial primary completion date: Dec 2022 --> Aug 2024
Trial completion date • Trial primary completion date
7ms
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia (clinicaltrials.gov)
P4, N=26, Completed, Weill Medical College of Cornell University | N=47 --> 26
Enrollment change
7ms
Adverse hematological profiles associated with chlorpromazine antipsychotic treatment in male rats: Preventive and reversal mechanisms of taurine and coenzyme-Q10. (PubMed, Toxicol Rep)
Taurine and COQ-10 alone notably improved the antioxidant/anti-inflammatory status relative to controls. Among other mechanisms, taurine and COQ-10 abated CPZ-induced hematological deficiencies, via decreased serum levels of oxidative stress, and pro-inflammatory cytokines release, with increased antioxidants and anti-inflammation function.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10)
|
IL10 elevation
|
chlorpromazine
7ms
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia (clinicaltrials.gov)
P4, N=60, Recruiting, All India Institute of Medical Sciences, Bhubaneswar | Not yet recruiting --> Recruiting
Enrollment open
8ms
The cytotoxic effects of prazosin, chlorpromazine, and haloperidol on hepatocellular carcinoma and immortalized non-tumor liver cells. (PubMed, Med Oncol)
Based on our findings, a mechanism of cell death was not able to be established due to lack of cleaved caspase-3 expression. Capable of bypassing many aspects of the lengthy, costly, and difficult cancer drug approval process, chlorpromazine and prazosin deserve further investigation for use in conjunction with traditional chemotherapeutics.
Journal
|
CASP3 (Caspase 3)
|
chlorpromazine
8ms
A retrotransposon-derived DNA zip code internalizes myeloma cells through Clathrin-Rab5a-mediated endocytosis. (PubMed, Front Oncol)
Endocytosis inhibitors identified that Monensin and Chlorpromazine hydrochloride significantly reduced MM-ZC internalization...Overall, the current study provides valuable insights into the cellular uptake and intracellular trafficking of MM-ZC in myeloma cells. Identifying these mechanisms and molecular players involved in MM-ZC uptake contributes to a better understanding of the delivery and potential applications of cell-specific Zip-Codes in gene delivery and drug targeting in cancer research.
Journal
|
RAB5A (Ras-related protein Rab-5A)
|
chlorpromazine
9ms
Striatal Connectivity and Clinical Outcome in Psychosis (clinicaltrials.gov)
P=N/A, N=196, Completed, Northwell Health | Recruiting --> Completed
Trial completion
9ms
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia (clinicaltrials.gov)
P4, N=60, Not yet recruiting, All India Institute of Medical Sciences, Bhubaneswar
New P4 trial
9ms
LAP01: Long-term Antipsychotic Pediatric Safety Trial (clinicaltrials.gov)
P=N/A, N=509, Completed, Duke University | Active, not recruiting --> Completed
Trial completion
9ms
Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75-IP3R-Ca2+ -AMPK Axis. (PubMed, Adv Sci (Weinh))
Mechanistically, the direct binding of JX57 to GRP75 impairs the structure of the mitochondria-associated endoplasmic reticulum membrane and disrupts the endoplasmic reticulum-mitochondrial calcium homeostasis, resulting in a mitochondrial energy crisis and AMP-activated protein kinase activation. Taken together, these findings highlight GRP75 as a potential prognostic biomarker and direct therapeutic target in endometrial cancer and suggest that the chlorpromazine derivative JX57 can potentially be a new therapeutic option for endometrial cancer.
Journal
|
AMPK (Protein Kinase AMP-Activated Catalytic Subunit Alpha 1) • HSPA9 (Heat Shock Protein Family A (Hsp70) Member )
9ms
Risperidone for the Treatment of Huntington's Disease Involuntary Movements (clinicaltrials.gov)
P2, N=5, Completed, University of Rochester | Suspended --> Completed
Trial completion
10ms
New P1 trial
11ms
Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial. (PubMed, Front Oncol)
In this phase II clinical trial, we evaluated the addition of chlorpromazine to temozolomide in the adjuvant phase of the standard first-line therapeutic protocol in patients with unmethylated MGMT gene promoter. These findings provide proof-of-concept for the potential of adding CPZ to standard TMZ treatment in GBM patients with unmethylated MGMT gene promoter. https://clinicaltrials.gov/study/NCT04224441, identifier NCT04224441.
P2 data • Journal
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
temozolomide • chlorpromazine
11ms
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2. (PubMed, Cell Death Dis)
The effect of CPZ can be epitomized as an inhibition of the Warburg effect and thus malignancy in GBM cells, while sparing RPE-1 cells. These preclinical data enforce the rationale that allowed us to investigate the role of CPZ in GBM treatment in a recent multicenter Phase II clinical trial.
Journal
|
PKM (Pyruvate Kinase M1/2)
12ms
New P1 trial
|
chlorpromazine
1year
New trial
|
olanzapine
1year
RACTAC trial: Phase II multicentric italian trial on Repositioning of the Antipsychotic drug Chlorpromazine and its combination with Temozolomide in MGMT unmethylated glioblastoma patients (SNO 2023)
6,9). The addition of Chlorpromazine to temozolomide was well tolerated in newly diagnosed Glioblastoma unmethylated patients, with promising impact on outcome measures.
Clinical • P2 data
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
temozolomide • chlorpromazine
1year
R21NR016736: Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer (clinicaltrials.gov)
P2/3, N=70, Active, not recruiting, M.D. Anderson Cancer Center | Trial completion date: Jun 2023 --> Jun 2025
Trial completion date • Metastases
|
chlorpromazine
over1year
Chlorpromazine and Standard of Care in Glioblastoma (clinicaltrials.gov)
P1, N=15, Recruiting, Mohammed Milhem | Trial completion date: Jun 2025 --> Jul 2024 | Trial primary completion date: Jun 2023 --> Jul 2024
Trial completion date • Trial primary completion date
|
temozolomide • chlorpromazine
over1year
Gut Feelings: A Case of Psychotropic Prescribing Post-Total Gastrectomy and Review of Psychotropic Bioavailability After Bariatric Surgery (APA 2023)
For this case, the patient was stable on oral duloxetine, risperidone, and amitriptyline, all of which have been described in the literature to have decreased absorption after bariatric surgery.[1][2] Importantly, while oral risperidone can be easily transitioned to ODT risperidone, the literature suggests that Roux-en-Y Gastric Bypass likely decreases absorption of oral Duloxetine, and this might persist for at least 12 months after surgery.[2] Given the variability of absorption among psychotropics in an altered GI environment, the only current perioperative psychopharmacologic recommendation is to avoid extended-release preparation of medications when possible and maintain psychotropic regimens and closely monitor if a patient is stable on their current regimen. [1]
Clinical • Review • Surgery • Bariatric surgery
|
CDH1 (Cadherin 1)
|
CDH1 mutation
|
amitriptyline
over1year
Refractory Psychosis in a Patient With an Arachnoid Cyst (APA 2023)
Patient was symptomatically treated with Risperidone with no significant improvement...Numerous cases have been reported with psychiatric symptoms in the presence of arachnoid cyst, of which, some were reported with significant improvement after surgical decompression. We briefly review and highlight the available literature on the subject, discuss the mechanisms by which cysts can cause neuropsychiatric symptoms, and suggest future studies investigating this association and the role for neurosurgery.
Clinical
over1year
THE PHASE II STUDY OF ME2136 PLUS STANDARD ANTIEMETIC THERAPY FOR PATIENTS INCLUDING DIABETIC PATIENTS UNDERGOING CISPLATIN-BASED CHEMOTHERAPY (MASCC-JASCC-ISOO 2023)
Introduction Olanzapine is combined with aprepitant, palonosetron, and dexamethasone to prevent chemotherapy-induced nausea and vomiting. Grade 2 adverse events were delirium and dizziness in one patient each. Conclusions ME2136 plus standard antiemetic therapy was safe and had a certain efficacy in patients receiving cisplatin-based chemotherapy with or without DM.
Clinical • P2 data
|
cisplatin • dexamethasone • olanzapine
over1year
Multilevel Pharmacological Effects of Antipsychotics in Potential Glioblastoma Treatment. (PubMed, Curr Top Med Chem)
Despite current treatment options such as surgery, radiotherapy, and the use of temozolomide and bevacizumab, it is considered incurable...Typical antipsychotics include chlorpromazine, trifluoperazine, and pimozide...Olanzapine and Quetiapine are examples of atypical antipsychotics, a category that was created later...These include NF-B suppression, cyclin deregulation, and -catenin phosphorylation, among others. This review will delve deeper into the polypharmacological, the multiple effects of antipsychotics in the treatment of GBM, and an outlook for the field's future progression.
Journal
|
DRD2 (Dopamine Receptor D2)
|
Avastin (bevacizumab) • temozolomide • chlorpromazine • olanzapine
over1year
Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells. (PubMed, J Med Chem)
In this study, the antipsychotic drug chlorpromazine was characterized as an LSD1 inhibitor (IC = 5.135 μM), and a series of chlorpromazine derivatives were synthesized...An in vivo study confirmed that compound 3s can inhibit MFC cell proliferation without significant toxicity in immunocompetent mice. Taken together, our findings indicated that the novel LSD1 inhibitor 3s tethering a phenothiazine scaffold may serve as a lead compound for further development to activate T-cell immunity in gastric cancer.
Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1)
|
chlorpromazine
2years
TRAF4 maintains deubiquitination of Caveolin-1 to drive glioblastoma stemness and Temozolomide resistance. (PubMed, Cancer Res)
Screening of common nervous system drugs identified risperidone interaction with TRAF4, and risperidone treatment resulted in the dissociation of TRAF4 and CAV1. Importantly, pharmacological inhibition of TRAF4 with Risperidone potently inhibited self-renewal, abrogated tumorigenicity, and reversed TMZ resistance in GBM. Overall, TRAF4-mediated stabilization of CAV1 promotes stemness and TMZ resistance in GBM, providing a therapeutic strategy that could improve patient outcomes.
Journal
|
CAV1 (Caveolin 1) • USP7 (Ubiquitin Specific Peptidase 7)
|
temozolomide